logo
Plus   Neg
Share
Email

Snap Q1 Results Beat Street View On User Growth, Shares Up 5%

Shares of Snap Inc. (SNAP) gained nearly 5% in extended trading session on Thursday after the company's first-quarter earnings and revenues trumped Wall Street analysts' estimates, driven by strong user growth.

First-quarter net loss was $286.9 million or $0.19 per share, narrower than last year's loss of $305.9 million or $0.21 per share last year.

Adjusted earnings for the quarter were $0.00 per share, compared to a loss of $0.08 per share last year.

Revenues grew 66% to $769.6 million from $462.5 million last year.

Analysts polled by Thomson Reuters expected loss of $0.05 per share on revenues of $743.01 million for the quarter. Analysts' estimates typically exclude special items.

DAUs were 280 million in first quarter of 2021, an increase of 51 million, or 22%, year-over-year. DAUs increased sequentially and year-over-year in each of North America, Europe, and Rest of World.

Looking forward to the second quarter, revenues is estimated to be between $820 million and $840 million. Analysts currently estimate revenues of $826.11 million.

SNAP closed Thursday's trading at $57.05, down $1.25 or 2.14%, on the Nasdaq. The stock, however, gained $2.75 or 4.82%, in the after-hours trade.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Performance Food Group Co. announced Tuesday its agreement to acquire Core-Mark Holding Co., Inc., a wholesale distributor to the convenience retail industry, in around $2.5 billion stock and cash transaction, including net debt. In pre-markey activity on Nasdaq, Core-Mark shares were gaining around 9 percent to trade at $45.86. Retail giant Walmart Inc. reported Tuesday a profit for the first quarter of fiscal 2022 that declined 31.6 percent from last year, hurt by net losses on equity investments, However, adjusted earnings per share and quarterly revenues topped analysts' expectations. The retailer also raised its guidance for the second quarter and for the full-year 2022. European Medicines Agency or EMA announced that Comirnaty, the COVID-19 vaccine developed by Pfizer and BioNTech, can have more flexible storage conditions, including up to one month in a normal fridge. The proposed change in the approved storage conditions, recommended by EMA's human medicines committee or CHMP, will help in easy handling of the vaccine in vaccination centres across the EU.
RELATED NEWS
Follow RTT